首页> 外文期刊>Haematologica >Human hematopoietic stem/progenitor cells display reactive oxygen species-dependent long-term hematopoietic defects after exposure to low doses of ionizing radiations
【24h】

Human hematopoietic stem/progenitor cells display reactive oxygen species-dependent long-term hematopoietic defects after exposure to low doses of ionizing radiations

机译:人造血干/祖细胞在暴露于低剂量的电离辐射后显示反应性氧物质依赖性的长期造血缺陷

获取原文
获取外文期刊封面目录资料

摘要

Hematopoietic stem cells are responsible for life-long blood cell production and are highly sensitive to exogenous stresses. The effects of low doses of ionizing radiations on radiosensitive tissues such as the hematopoietic tissue are still unknown despite their increasing use in medical imaging. Here, we study the consequences of low doses of ionizing radiations on differentiation and self-renewal capacities of human primary hematopoietic stem/progenitor cells (HSPC). We found that a single 20 mGy dose impairs the hematopoietic reconstitution potential of human HSPC but not their differentiation properties. In contrast to high irradiation doses, low doses of irradiation do not induce DNA double strand breaks in HSPC but, similar to high doses, induce a rapid and transient increase of reactive oxygen species (ROS) that promotes activation of the p38MAPK pathway. HSPC treatment with ROS scavengers or p38MAPK inhibitor prior exposure to 20 mGy irradiation abolishes the 20 mGy-induced defects indicating that ROS and p38MAPK pathways are transducers of low doses of radiation effects. Taken together, these results show that a 20 mGy dose of ionizing radiation reduces the reconstitution potential of HSPC suggesting an effect on the self-renewal potential of human hematopoietic stem cells and pinpointing ROS or the p38MAPK as therapeutic targets. Inhibition of ROS or the p38MAPK pathway protects human primary HSPC from low-dose irradiation toxicity.
机译:造血干细胞负责终生血细胞产生,对外源应力高度敏感。尽管在医学成像中不断增加,但低剂量电离辐射对造血组织的放射敏感组织的影响仍然是未知的。在这里,我们研究低剂量电离辐射对人原发性造血干/祖细胞(HSPC)的分化和自我更新能力的后果。我们发现单一20 MGY剂量损害人HSPC的造血重构潜力,但不是它们的分化特性。与高辐射剂量相比,低剂量的照射不诱导HSPC中的DNA双链断裂,但类似于高剂量,诱导促进P38MAPK途径的活化的活性氧物质(ROS)的快速和瞬时增加。 HSPC治疗与ROS清除剂或P38MAPK抑制剂预先暴露于20 MGY辐照,消除了20种成熟的缺陷,表明ROS和P38MAPK途径是低剂量辐射效应的换能器。总之,这些结果表明,20 MGY剂量的电离辐射减少了HSPC的重构潜力,表明对人造造血干细胞的自我更新潜力的影响,并针对治疗靶标的ROS或P38MAPK。 ROS或P38MAPK途径的抑制保护人原发性HSPC免受低剂量照射毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号